Reporting Manager
Rubric Capital Management LP
Symbol
ADPT
Shares outstanding
151,865,218 shares
Disclosed Ownership
6,256,847 shares
Ownership
4.1%
Form type
SCHEDULE 13G/A
Filing time
09 Jul 2025, 16:07:47 UTC
Date of event
30 Jun 2025

Sponsored

Quoteable Key Fact

"Rubric Capital Management LP disclosed 4.1% ownership in Adaptive Biotechnologies Corporation Common stock, par value $0.0001 per share (ADPT) on 30 Jun 2025."

Quick Takeaways

  • Rubric Capital Management LP filed SCHEDULE 13G/A for Adaptive Biotechnologies Corporation Common stock, par value $0.0001 per share (ADPT).
  • Disclosed ownership: 4.1%.
  • Date of event: 30 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 09 Jul 2025, 16:07.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Rubric Capital Management LP 4.1% 6,256,847 0 6,256,847 /s/ Michael Nachmani Michael Nachmani / Chief Operating Officer
David Rosen 4.1% 6,256,847 0 6,256,847 /s/ David Rosen David Rosen, Individually